|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hashibe M, Brennan P, Chuang SC, Boccia S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, et al: Interaction between tobacco and alcohol use and the risk
of head and neck cancer: Pooled analysis in the international head
and neck cancer epidemiology consortium. Cancer Epidemiol
Biomarkers Prev. 18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan DS, Wang W, Leong HS, Sew PH, Lau DP,
Chong FT, Krisna SS, Lim TK and Iyer NG: Tongue carcinoma
infrequently harbor common actionable genetic alterations. BMC
Cancer. 14:6792014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng Z, Xu QS, Qin LZ, Li H and Han Z:
Predicting radiotherapy necessity in tongue cancer using lymph Node
Yield. J Oral Maxillofac Surg. 75:1062–1070. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Epstein JB, Thariat J, Bensadoun RJ,
Barasch A, Murphy BA, Kolnick L, Popplewell L and Maghami E: Oral
complications of cancer and cancer therapy: From cancer treatment
to survivorship. CA Cancer J Clin. 62:400–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sacco AG and Cohen EE: Current treatment
options for recurrent or metastatic head and neck squamous cell
carcinoma. J Clin Oncol. 33:3305–3313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Milanesi E, Bonvicini C, Alberici A,
Pilotto A, Cattane N, Premi E, Gazzina S, Archetti S, Gasparotti R,
Cancelli V, et al: Molecular signature of disease onset in Granulin
mutation carriers: A gene expression analysis study. Neurobiol
Aging. 34:1837–1845. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou H, Shi R, Wei M, Zheng WL, Zhou JY
and Ma WL: The expression and clinical significance of HERC4 in
breast cancer. Cancer Cell Int. 13:1132013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dissanayaka WL, Pitiyage G, Kumarasiri PV,
Liyanage RL, Dias KD and Tilakaratne WM: Clinical and
histopathologic parameters in survival of oral squamous cell
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 113:518–525.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin CS, de Oliveira SA, Silva EL, de Matos
LL, Moyses RA, Kulcsar MA, Pinto FR, Brandão LG and Cernea CR:
Tumor volume as an independent predictive factor of worse survival
in patients with oral cavity squamous cell carcinoma. Head Neck.
39:960–964. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dumache R, Rogobete AF, Andreescu N and
Puiu M: Genetic and epigenetic biomarkers of molecular alterations
in oral carcinogenesis. Clin Lab. 61:1373–1381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jo DW, Kim YK and Yun PY: The influence of
p53 mutation status on the anti-cancer effect of cisplatin in oral
squamous cell carcinoma cell lines. J Korean Assoc Oral Maxillofac
Surg. 42:337–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao J, Ulekleiv CH and Halstensen TS:
Epidermal growth factor (EGF) receptor-ligand based molecular
staging predicts prognosis in head and neck squamous cell carcinoma
partly due to deregulated EGF-induced amphiregulin expression. J
Exp Clin Cancer Res. 35:1512016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ramos-Garcia P, Gil-Montoya JA, Scully C,
Ayén A, González-Ruiz L, Navarro-Triviño FJ and González-Moles MA:
An update on the implications of Cyclin D1 in oral carcinogenesis.
Oral Dis. 23:897–912. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murali A, Varghese BT, Kumar RR and Kannan
S: Combination of genetic variants in cyclin D1 and retinoblastoma
genes predict clinical outcome in oral cancer patients. Tumour
Biol. 37:3609–3617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ,
Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH and Tai CK: DNA
methylation profiles and biomarkers of oral squamous cell
carcinoma. Epigenetics. 10:229–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gkouveris I, Nikitakis N, Karanikou M,
Rassidakis G and Sklavounou A: JNK1/2 expression and modulation of
STAT3 signaling in oral cancer. Oncol Lett. 12:699–706. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brauswetter D, Danos K, Gurbi B,
Félegyházi ÉF, Birtalan E, Meggyesházi N, Krenács T, Tamás L and
Peták I: Copy number gain of PIK3CA and MET is associated with poor
prognosis in head and neck squamous cell carcinoma. Virchows Arch.
468:579–587. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang ZF, Zhang HR, Zhang QY, Lai SY, Feng
YZ, Zhou Y, Zheng SR, Shi R and Zhou JY: High expression of TMEM40
is associated with the malignant behavior and tumorigenesis in
bladder cancer. J Transl Med. 16:92018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duplan E, Giaime E, Viotti J, Sévalle J,
Corti O, Brice A, Ariga H, Qi L, Checler F and Alves da Costa C:
ER-stress-associated functional link between Parkin and DJ-1 via a
transcriptional cascade involving the tumor suppressor p53 and the
spliced X-box binding protein XBP-1. J Cell Sci. 126:2124–2133.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Follis AV, Llambi F, Merritt P, Chipuk JE,
Green DR and Kriwacki RW: Pin1-induced proline isomerization in
cytosolic p53 mediates BAX activation and apoptosis. Mol Cell.
59:677–684. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu L, Zhang J, Shi M, Zhan Q, Shen B and
Peng C: lncRNA MEG3 had anti-cancer effects to suppress pancreatic
cancer activity. Biomed Pharmacother. 89:1269–1276. 2017.
View Article : Google Scholar : PubMed/NCBI
|
